These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1500 related articles for article (PubMed ID: 30267887)
1. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
2. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730 [TBL] [Abstract][Full Text] [Related]
3. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
4. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles. Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846 [TBL] [Abstract][Full Text] [Related]
5. cRGDyK modified pH responsive nanoparticles for specific intracellular delivery of doxorubicin. Qiu L; Hu Q; Cheng L; Li L; Tian C; Chen W; Chen Q; Hu W; Xu L; Yang J; Cheng L; Chen D Acta Biomater; 2016 Jan; 30():285-298. PubMed ID: 26602824 [TBL] [Abstract][Full Text] [Related]
6. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery. Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507 [TBL] [Abstract][Full Text] [Related]
7. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery. Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060 [TBL] [Abstract][Full Text] [Related]
8. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810 [TBL] [Abstract][Full Text] [Related]
9. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release. Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711 [TBL] [Abstract][Full Text] [Related]
10. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery. Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging. Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105 [TBL] [Abstract][Full Text] [Related]
12. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species. Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304 [TBL] [Abstract][Full Text] [Related]
14. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor. Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653 [TBL] [Abstract][Full Text] [Related]
15. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging. Xie P; Du P; Li J; Liu P Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118 [TBL] [Abstract][Full Text] [Related]
16. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer. Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733 [TBL] [Abstract][Full Text] [Related]
18. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin. Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505 [TBL] [Abstract][Full Text] [Related]
19. Detachable Polyzwitterion-Coated Ternary Nanoparticles Based on Peptide Dendritic Carbon Dots for Efficient Drug Delivery in Cancer Therapy. Ma J; Kang K; Zhang Y; Yi Q; Gu Z ACS Appl Mater Interfaces; 2018 Dec; 10(50):43923-43935. PubMed ID: 30474366 [TBL] [Abstract][Full Text] [Related]
20. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity. Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]